Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets
NEW YORK, Sept. 22, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0619263/Global-Markets-for-Contract-Pharmaceutical-Manufacturing-Research-And-Packaging-Focus-on-Emerging-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing
REPORT HIGHLIGHTS
* The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.
* The Rest of World (ROW) and emerging markets had revenue of approximately $10.5 billion in 2010, which increased to $11.2 billion in 2011 in the bulk drugs/API market. The revenue of this market is expected to rise to $15.5 billion in 2016, with the CAGR expected to rise at 6.7%.
* The ROW market for contract manufacturers that produce solid dosage forms including tablets and capsules had revenue of $2.9 billion in 2010. The ROW market revenue for the solid dosage form is projected to reach $7 billion by the end of 2016 while increasing at a CAGR of 15.5%.
INTRODUCTION
STUDY OBJECTIVE
The objective of BCC Research in conducting this study is to provide an overview of the current situation and future capabilities of the global pharmaceutical contract manufacturing, research, and packaging markets. The study provides a global as well as a regionally specific market overview. The report emphasizes the current and future outlook of the pharmaceutical contract manufacturing market, with a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.
The current report discusses and outlines the current capabilities as well as the needs of the pharmaceutical contract manufacturing, research, and packaging markets. In addition, it discusses company and market strategies to further enhance the market. The report includes the different types of contract manufacturing and, more specifically, the services offered by global contract manufacturers, researchers, and packagers. The report also discusses the methods best used to identify an effective contract manufacturer as well as the advantages of contract manufacturing and outsourcing. The REPORT HIGHLIGHTS the need for project management, provides market forecasts for different aspects of contract manufacturing specific to each region, and examines the role of market leaders in the industry. Regulatory requirements and new developments in the market are also discussed in the report.
The report encompasses the revenues gained from contract manufacturing in each specific market and in each specific region. Sales analysis was performed on specific categories of drugs and dosage forms including API/bulk drugs and solid, liquid, and semisolid dosage forms. Sales analyses were also performed on revenues gained from contract packaging and contract research. The sales figures discussed are for the examined period of 2009 to 2011. Sales figures were also forecast for the following 5-year period from 2011 through 2016.
Over-the-counter (OTC) drugs, nutritional drugs, and drug delivery products are discussed in a separate section of this report.
REASONS FOR DOING THIS STUDY
The majority of pharmaceutical companies are now using contract manufacturing, research, and packaging services. To save costs and product development time while simultaneously being effective, efficient, and productive, pharmaceutical companies are relying on contract manufacturers to fulfill many basic as well as specialized competencies. This study discusses the different types of contracting companies, their roles, and the share of the market they claim. New developments and new technologies warrant the issuing of this report, which is an important resource for anyone analyzing the discussed markets.
Trends in outsourcing and new emerging markets for outsourcing are providing a new look to the market and greater options to pharmaceutical companies. The industry is seeing an increase in outsourcing as contract manufacturers, researchers, and packagers provide cheaper options as well as region-specific suppliers. The new state-of-the-art packaging facilities as well as expensive research facilities and capabilities of research organizations are enhancing the overall growth of the contract manufacturing industry. Contract manufacturers are providing pharmaceutical companies with expertise in all forms that the companies do not have available in-house.
INTENDED AUDIENCE
This study examines the areas of market growth in pharmaceuticals contract manufacturing, research, and packaging from the point of view of manufacturers and users. Strategic decision makers at biochemical and biotechnology companies, physicians, pharmaceuticals and biopharmaceuticals companies, and related research companies will find value in this study.
SCOPE OF THE STUDY
The scope of this study encompasses the contract manufacturing, research, and packaging markets. BCC analyzes each market and its applications for contract manufacturing by its need for outsourcing, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical, and contracting experts. Market sizing estimates and projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.
CHAPTER ONE: INTRODUCTION 1
STUDY OBJECTIVE 1
REASONS FOR DOING THIS STUDY 1
INTENDED AUDIENCE 2
SCOPE OF THE STUDY 2
METHODOLOGY 2
INFORMATION SOURCES 3
ABOUT THE AUTHOR 3
RELATED BCC RESEARCH REPORTS 3
BCC ONLINE SERVICES 4
DISCLAIMER 4
CHAPTER TWO: SUMMARY 5
SUMMARY 5
SUMMARY (CONTINUED) 6
SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT
MANUFACTURING AND CONTRACT RESEARCH
ORGANIZATIONS REVENUE, THROUGH 2016 ($ BILLIONS) 7
SUMMARY FIGURE GLOBAL PHARMACEUTICAL CONTRACT
MANUFACTURING AND CONTRACT RESEARCH
ORGANIZATIONS REVENUE, 2009-2016 ($ BILLIONS) 7
CHAPTER THREE: OVERVIEW 8
DEFINITIONS 8
DEFINITIONS (CONTINUED) 9
HISTORY OF OUTSOURCING 10
TABLE 1 KEY DEVELOPMENTS IN THE HISTORY OF
OUTSOURCING 10
TABLE 1 (CONTINUED) 11
CHAPTER FOUR: OVERVIEW OF CONTRACT MANUFACTURING 12
TYPES OF CONTRACT MANUFACTURERS 12
CONTRACT MANUFACTURING TRAITS 12
REQUIREMENT 12
ABILITY TO BE FLEXIBLE 13
CAPABILITIES WITHOUT COST 13
ADVANTAGES AND DISADVANTAGES OF CONTRACT
MANUFACTURING 13
TABLE 2 KEY ADVANTAGES OF CONTRACT MANUFACTURING 14
TABLE 3 KEY DISADVANTAGES OF CONTRACT MANUFACTURING 14
SELECTING A CONTRACT MANUFACTURER 14
TABLE 4 KEY FACTORS IN SELECTING A CONTRACT
MANUFACTURER 15
TABLE 4 (CONTINUED) 16
ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURING 16
LOCATION AND PROXIMITY 16
AFTER-SALES SUPPORT 16
CHAPTER FIVE: OVERVIEW OF CONTRACT RESEARCH 17
OVERVIEW OF CONTRACT RESEARCH 17
SERVICES OFFERED BY CONTRACT RESEARCH
ORGANIZATIONS 18
TABLE 5 SERVICES OF CONTRACT RESEARCH ORGANIZATIONS 18
TABLE 5 (CONTINUED) 19
SELECTING A CONTRACT RESEARCH ORGANIZATION 19
TABLE 6 KEY CHARACTERISITCS IN SELECTING A CONTRACT
RESEARCH ORGANIZATION 19
TABLE 6 (CONTINUED) 20
RESEARCH PROVIDED BY CONTRACT RESEARCH
ORGNIZATIONS 20
TABLE 7 TYPES OF RESEARCH PROVIDED BY CONTRACT
RESEARCH ORGANIZATIONS 20
TABLE 7 (CONTINUED) 21
CHAPTER SIX: OVERVIEW OF CONTRACT PACKAGING 22
NEEDING A CONTRACT PACKAGER 22
TABLE 8 REASONS BEHIND NEEDING A CONTRACT PACKAGER 22
TABLE 8 (CONTINUED) 23
SELECTING A CONTRACT PACKAGER 23
TABLE 9 KEY CHARACTERISTICS IN SELECTING A CONTRACT
PACKAGER 24
HIRING A CONTRACT PACKAGER 24
TABLE 10 KEY STEPS IN HIRING A CONTRACT PACKAGER 25
TYPES OF PACKAGING 25
TYPES OF PACKAGING (CONTINUED) 26
CHAPTER SEVEN: PROJECT MANAGEMENT 27
SPECIFICATIONS OF PROJECT MANAGEMENT 27
TABLE 11 STEPS OF PROJECT MANAGEMENT 27
TABLE 11 (CONTINUED) 28
PROCESSES OF PROJECT MANAGEMENT 28
TABLE 12 PROCESSES OF PROJECT MANAGEMENT 28
TABLE 12 (CONTINUED) 29
FACTORS INVOLVED 29
ROLE OF THE PROJECT MANAGER 29
TABLE 13 KEY RESPONSIBILITIES OF PROJECT MANAGERS 30
TECHNOLOGY TRANSFER 30
TABLE 14 TECHNOLOGY TRANSFER STEPS 31
CHAPTER EIGHT: REGULATORY ASPECTS 32
REGULATORY ASPECTS 32
TABLE 15 REGULATED FACTORS OF CMO'S AND CRO'S 33
TABLE 16 TITLE 21 CFR RULES ASSOCIATED WITH CONTRACT
MANUFACTURING 33
TABLE 16 (CONTINUED) 34
TABLE 16 (CONTINUED) 35
WARNING LETTERS 36
TABLE 17 WARNING LETTERS ISSUED TO CONTRACT
MANUFACTURERS, 2010 36
TABLE 18 WARNING LETTERS ISSUED TO CONTRACT
MANUFACTURERS, 2009 37
REGULATORY APPROVALS 37
TABLE 19 REGULATORY APPROVALS OF CONTRACT
MANUFACTURERS AND FACILITIES, JANUARY THROUGH
MARCH, 2011 38
TABLE 20 REGULATORY APPROVALS OF CONTRACT
MANUFACTURERS AND FACILITIES, 2010 38
TABLE 20 (CONTINUED) 39
TABLE 21 REGULATORY APPROVALS OF CONTRACT
MANUFACTURERS AND FACILITIES, 2009 39
TABLE 21 (CONTINUED) 40
CHAPTER NINE: INDUSTRY STRUCTURE FOR EMERGING MARKETS 41
MARKET SHARE OF INDUSTRY LEADERS 41
CONTRACT MANUFACTURERS OF BULK DRUGS AND API'S 41
TABLE 22 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING BULK DRUGS/API'S, IN REST OF
WORLD, 2010 (%) 42
FIGURE 1 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING BULK DRUGS/API'S, IN REST OF
WORLD, 2010 (%) 42
CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS 43
TABLE 23 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING SOLID DOSAGE FORMS, 2010 (%) 43
FIGURE 2 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING SOLID DOSAGE FORMS, IN REST OF
WORLD, 2010 (%) 44
CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS 44
NONSTERILE 44
TABLE 24 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,
IN REST OF WORLD, 2010 (%) 45
FIGURE 3 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS,
IN REST OF WORLD, 2010 (%) 45
STERILE 46
TABLE 25 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN
REST OF WORLD, 2010 (%) 46
FIGURE 4 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN
REST OF WORLD, 2010 (%) 47
CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS 47
TABLE 26 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN REST
OF WORLD, 2010 (%) 48
FIGURE 5 MARKET SHARE OF CONTRACT MANUFACTURING
COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN REST
OF WORLD, 2010 (%) 48
CONTRACT RESEARCH COMPANIES 48
TABLE 27 MARKET SHARES OF CONTRACT RESEARCH
COMPANIES, IN REST OF WORLD, 2010 (%) 49
FIGURE 6 MARKET SHARES OF CONTRACT RESEARCH
COMPANIES, IN REST OF WORLD, 2010 (%) 49
CONTRACT PACKAGING COMPANIES 50
TABLE 28 MARKET SHARE OF CONTRACT PACKAGING
COMPANIES, IN REST OF WORLD, 2010 (%) 50
FIGURE 7 MARKET SHARE OF CONTRACT PACKAGING
COMPANIES, IN REST OF WORLD, 2010 (%) 51
TYPES OF CONTRACT MANUFACTURING AND RESEARCH
FIRMS 51
TABLE 29 SERVICES PROVIDED BY CONTRACT MANUFACTURING
AND RESEARCH FIRMS 52
TABLE 29 (CONTINUED) 53
TABLE 30 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS
BY PACKAGING TYPE 54
CHAPTER TEN: TECHNOLOGY TRANSFER 55
REASONS FOR TECHNOLOGY TRANSFER 55
CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER 56
TECHNOLOGY TRANSFER 57
STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER 57
TYPES OF CONTRACTUAL AGREEMENTS USED IN
TECHNOLOGY TRANSFER 58
CONFIDENTIAL DISCLOSURE AGREEMENT (CDA) 59
MATERIAL TRANSFER AGREEMENT (MTA) 59
ASSIGNMENT DEED 59
LICENSE AGREEMENT 60
CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS 60
CHARACTERISTICS OF A SUCCESSFUL PROJECT 60
CHARACTERISTICS OF A SUCCESSFUL … (CONTINUED) 61
CHAPTER ELEVEN: NEW DEVELOPMENTS 62
LONZA 62
ABBOTT 63
HOSPIRA 64
COVIDIEN 64
OTHER 65
OTHER (CONTINUED) 66
CHAPTER TWELVE: MARKET ANALYSIS FOR REST OF
WORLD/EMERGING MARKETS 67
CONTRACT MANUFACTURING 67
CONTRACT MANUFACTURE OF BULK DRUGS/API'S 67
Market Overview 67
Market Revenue 68
TABLE 31 REST OF WORLD BULK DRUG/API'S CONTRACT
MANUFACTURING REVENUE, THROUGH 2016 ($ BILLIONS) 69
FIGURE 8 REST OF WORLD BULK DRUG/API'S CONTRACT
MANUFACTURING REVENUE, 2009-2016 ($ BILLIONS) 69
CONTRACT MANUFACTURE OF ORAL DOSAGE
FORMULATIONS* 69
Solid Dosage Formulations 70
Market Overview 70
Market Revenue 71
TABLE 32 SOLID DOSAGE FORM CONTRACT MANUFACTURING,
FOR REST OF WORLD, THROUGH 2016 ($ BILLIONS) 71
FIGURE 9 SOLID DOSAGE FORM CONTRACT MANUFACTURING,
FOR REST OF WORLD, 2009-2016 ($ BILLIONS) 72
Market by Formulation 72
Market Revenue 72
TABLE 33 SOLID DOSAGE FORM CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD,
THROUGH 2016 ($ BILLIONS) 73
FIGURE 10 SOLID DOSAGE FORM CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, 2009-2016
($ BILLIONS) 73
TABLE 34 SOLID DOSAGE FORM CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD,
2010 (%) 74
FIGURE 11 SOLID DOSAGE FORM CONTRACT MANUFACTURING
MARKET SHARE BY FORMULATION, FOR REST OF WORLD, 2010
(%) 74
Liquid Dosage Formulation 75
Market Overview 75
Market Revenue 75
Nonsterile Formulations 75
TABLE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING FOR REST OF WORLD, THROUGH 2016 ($
MILLIONS) 76
FIGURE 12 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING FOR REST OF WORLD, 2009-2016 ($
MILLIONS) 76
Sterile Formulations 77
TABLE 36 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING, FOR REST OF WORLD, THROUGH 2016 ($
MILLIONS) 77
FIGURE 13 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING, FOR REST OF WORLD, 2009-2016 ($
MILLIONS) 77
Market by Formulation 78
Nonsterile Formulations 78
TABLE 37 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF
WORLD, THROUGH 2016 ($ MILLIONS) 78
FIGURE 14 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF
WORLD, 2009-2016 ($ MILLIONS) 79
TABLE 38 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
REST OF WORLD, 2010 (%) 79
FIGURE 15 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
REST OF WORLD, 2010 (%) 80
Sterile Formulations 80
TABLE 39 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING REVENUE BY FORMULATION FOR REST OF
WORLD, THROUGH 2016 ($ MILLIONS) 81
FIGURE 16 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING REVENUE BY FORMULATION, FOR REST OF
WORLD, 2009-2016 ($ MILLIONS) 81
TABLE 40 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
REST OF WORLD, 2010 (%) 82
FIGURE 17 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
REST OF WORLD, 2010 (%) 82
CONTRACT MANUFACTURE OF SEMISOLID DOSAGE
FORMULATIONS 82
Market Overview 82
Market Revenue 83
TABLE 41 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING, FOR REST OF WORLD, THROUGH 2016 ($
MILLIONS) 84
FIGURE 18 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING, FOR REST OF WORLD, 2009-2016 ($
MILLIONS) 84
Market by Formulation 84
TABLE 42 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING REVENUE BY FORMULATION, FOR REST OF
WORLD, THROUGH 2016 ($ MILLIONS) 85
FIGURE 19 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING REVENUE BY FORMULATION, FOR REST OF
WORLD, 2009-2016 ($ MILLIONS) 85
TABLE 43 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING MARKET SHARE BY FORMULATION, FOR
REST OF WORLD, 2010 (%) 86
FIGURE 20 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING MARKET SHARE BY FORMULATION, FOR
REST OF WORLD, 2010 (%) 86
CONTRACT MANUFACTURE OF ADVANCED DRUG
DELIVERY PRODUCTS 86
Market Overview 87
TABLE 44 CONTRACTING COMPANIES PROVIDING DRUG
DELIVERY SYSTEMS IN ROW 88
TABLE 45 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY
CONTRACT MANUFACTURING, FOR REST OF WORLD,
THROUGH 2016 ($ BILLIONS) 88
FIGURE 21 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY
CONTRACT MANUFACTURING, FOR REST OF WORLD,
THROUGH 2016 ($ BILLIONS) 89
Market by Formulation 89
TABLE 46 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF
WORLD, THROUGH 2016 ($ MILLIONS) 90
FIGURE 22 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF
WORLD, 2009-2016 ($ MILLIONS) 90
Market Share 91
TABLE 47 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
REST OF WORLD, 2010 (%) 91
FIGURE 23 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
REST OF WORLD, 2010 (%) 92
CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL
PRODUCTS 92
Market Revenue 93
TABLE 48 OTC AND NUTRITIONAL PRODUCTS REVENUE BY
CONTRACT MANUFACTURING, FOR REST OF WORLD,
THROUGH 2016 ($ BILLIONS) 94
FIGURE 24 OTC AND NUTRITIONAL PRODUCTS REVENUE BY
CONTRACT MANUFACTURING, FOR REST OF WORLD, 2009-2016
($ BILLIONS) 94
TABLE 49 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR REST OF
WORLD, THROUGH 2016 ($ BILLIONS) 95
FIGURE 25 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATIONS, FOR REST
OF WORLD, 2009-2016 ($ BILLIONS) 96
Market Shares 96
TABLE 50 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
REST OF WORLD, 2010 (%) 96
FIGURE 26 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR
REST OF WORLD, 2009-2016 (%) 97
CONTRACT RESEARCH 97
MARKET OVERVIEW 97
Partnerships 97
Expansions of Facilities 98
Market Revenue 99
TABLE 51 CONTRACT RESEARCH REVENUE FOR REST OF WORLD,
THROUGH 2016 ($ BILLIONS) 99
FIGURE 27 CONTRACT RESEARCH REVENUE FOR REST OF
WORLD, 2009-2016 ($ BILLIONS) 100
Market by Discipline 100
TABLE 52 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR
REST OF WORLD, THROUGH 2016 ($ BILLIONS) 101
FIGURE 28 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR
REST OF WORLD, 2009-2016 ($ BILLIONS) 101
Market Shares by Discipline 102
TABLE 53 CONTRACT RESEARCH MARKET SHARE BY DISCIPLINE,
FOR REST OF WORLD, 2010 (%) 102
FIGURE 29 CONTRACT RESEARCH MARKET SHARE BY
DISCIPLINE, FOR REST OF WORLD, 2010 (%) 102
CONTRACT PACKAGING 103
MARKET OVERVIEW 103
TABLE 54 CONTRACT PACKAGING REVENUE, FOR REST OF
WORLD, THROUGH 2016 ($ BILLIONS) 104
FIGURE 30 CONTRACT PACKAGING REVENUE, FOR REST OF
WORLD, 2009-2016 ($ BILLIONS) 104
Market by Package Type 104
Market Revenue 105
TABLE 55 CONTRACT PACKAGING REVENUE BY TYPE, FOR REST
OF WORLD, THROUGH 2016 ($ MILLIONS) 105
FIGURE 31 CONTRACT RESEARCH REVENUE BY DISCIPLINE FOR
REST OF WORLD, THROUGH 2016 ($ MILLIONS) 106
Market Share by Type 106
TABLE 56 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR
REST OF WORLD, 2010 (%) 107
FIGURE 32 CONTRACT PACKAGING MARKET SHARE BY TYPE,
FOR REST OF WORLD, 2010 (%) 107
CHAPTER THIRTEEN: MARKET SHARE BY REGION 108
MARKET SHARE OF CONTRACT MANUFACTURED API'S 108
TABLE 57 BULK DRUG/API CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%) 108
FIGURE 33 BULK DRUG/API CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%) 109
MARKET SHARE OF CONTRACT MANUFACTURED SOLID
DOSAGE FORMS 109
TABLE 58 SOLID DOSAGE FORM CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%) 109
FIGURE 34 SOLID DOSAGE FORM CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%) 110
MARKET SHARE OF CONTRACT MANUFACTURED LIQUID
DOSAGE FORMULATIONS 110
NONSTERILE FORMULATIONS 110
TABLE 59 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 110
FIGURE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 111
STERILE FORMULATIONS 111
TABLE 60 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 111
FIGURE 36 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 112
MARKET SHARE OF CONTRACT MANUFACTURED SEMISOLID
DOSAGE FORMULATIONS 112
TABLE 61 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING MARKET SHARES, BY REGION, 2010 (%) 112
FIGURE 37 SEMISOLID DOSAGE FORM CONTRACT
MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 113
MARKET SHARE OF CONTRACT MANUFACTURED ADVANCED
DRUG DELIVERY PRODUCTS 113
TABLE 62 DRUG DELIVERY CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%) 113
FIGURE 38 DRUG DELIVERY CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%) 114
MARKET SHARE OF CONTRACT MANUFACTURED OTC AND
NUTRITIONAL PRODUCTS 114
TABLE 63 OTC AND NUTRITIONAL PRODUCTS CONTRACT
MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 114
FIGURE 39 OTC AND NUTRITIONAL PRODUCT CONTRACT
MANUFACTURING MARKET SHARE, BY REGION, 2010 (%) 115
MARKET SHARE OF CONTRACT RESEARCH 115
TABLE 64 CONTRACT RESEARCH MARKET SHARE, BY REGION,
2010 (%) 115
FIGURE 40 CONTRACT RESEARCH MARKET SHARE, BY REGION,
2010 (%) 116
MARKET SHARE OF CONTRACT PACKAGING 116
TABLE 65 CONTRACT PACKAGING MARKET SHARE, BY REGION,
2010 (%) 116
FIGURE 41 CONTRACT PACKAGING MARKET SHARE, BY REGION,
2010 (%) 117
CHAPTER FOURTEEN: CONTRACT MANUFACTURING APPLICATIONS
FOR REST OF THE WORLD (ROW) 118
CARDIOVASCULAR DRUGS 118
MARKET REVENUE 119
TABLE 66 REVENUE FROM CONTRACT MANUFACTURERS OF
CARDIOVASCULAR DRUGS, IN REST OF WORLD, THROUGH 2016
($ MILLIONS) 119
FIGURE 42 REVENUE FROM CONTRACT MANUFACTURERS OF
CARDIOVASCULAR DRUGS, IN REST OF WORLD, 2009-2016 ($
MILLIONS) 120
REPRODUCTIVE DRUG MARKET 120
MARKET REVENUE 121
TABLE 67 REVENUE FROM CONTRACT MANUFACTURERS OF
REPRODUCTIVE DRUGS, IN REST OF WORLD, THROUGH 2016 ($
MILLIONS) 122
FIGURE 43 REVENUE FROM CONTRACT MANUFACTURERS OF
REPRODUCTIVE DRUGS, IN REST OF WORLD, 2009-2016 ($
MILLIONS) 122
ONCOLOGY DRUG MARKET 122
MARKET REVENUE 123
TABLE 68 REVENUE FROM CONTRACT MANUFACTURERS OF
DRUGS USED IN ONCOLOGY, IN REST OF WORLD, THROUGH
2016 ($ MILLIONS) 124
FIGURE 44 REVENUE FROM CONTRACT MANUFACTURERS OF
DRUGS USED IN ONCOLOGY, IN REST OF WORLD, 2009-2016 ($
MILLIONS) 124
ANALGESICS MARKET 124
MARKET REVENUE 125
TABLE 69 REVENUE FROM CONTRACT MANUFACTURERS OF
ANALGESICS, IN REST OF WORLD, THROUGH 2016 ($
MILLIONS) 125
FIGURE 45 REVENUE FROM CONTRACT MANUFACTURERS OF
ANALGESICS, IN REST OF WORLD, 2009-2016 ($ MILLIONS) 126
ANTIVIRAL DRUG MARKET 126
MARKET REVENUE 127
TABLE 70 REVENUE FROM CONTRACT MANUFACTURERS OF
ANTIVIRALS, IN REST OF WORLD, THROUGH 2016 ($
MILLIONS) 127
FIGURE 46 REVENUE FROM CONTRACT MANUFACTURERS OF
ANTIVIRALS, IN REST OF WORLD, 2009-2016 ($ MILLIONS) 127
ANTIBIOTICS MARKET 128
MARKET REVENUE 128
TABLE 71 REVENUE FROM CONTRACT MANUFACTURERS OF
ANTIBIOTICS, IN REST OF WORLD, THROUGH 2016 ($
MILLIONS) 128
FIGURE 47 REVENUE FROM CONTRACT MANUFACTURERS OF
ANTIBIOTICS, IN REST OF WORLD, 2009-2016 ($ MILLIONS) 129
MARKETS FOR OTHER DRUGS 129
MARKET REVENUE 130
TABLE 72 REVENUE FROM CONTRACT MANUFACTURERS OF
OTHER DRUGS, IN REST OF WORLD, THROUGH 2016 ($
BILLIONS) 130
FIGURE 48 REVENUE FROM CONTRACT MANUFACTURERS OF
OTHER DRUGS, IN REST OF WORLD, 2009-2016 ($ BILLIONS) 130
CHAPTER FIFTEEN: PATENT ANALYSIS 131
PATENTS BY YEAR 131
TABLE 73 NUMBER OF SIGNIFICANT PATENTS, BY YEAR, 2009-
2011 131
FIGURE 49 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011 131
FIGURE 50 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011 (%) 132
PATENTS BY COMPANY 132
TABLE 74 NUMBER OF US PATENTS, BY COMPANY, 2009-2011 133
FIGURE 51 NUMBER OF US PATENTS, BY COMPANY, 2009-2011 134
PATENTS BY COUNTRY 135
TABLE 75 NUMBER OF US PATENTS, BY COUNTRY, 1/1/2009 TO
5/31/2011 135
FIGURE 52 NUMBER OF US PATENTS, BY COUNTRY, 1/1/2009 TO
5/31/2011 136
TABLE 76 PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011
(%) 136
FIGURE 53 PATENT SHARES, BY COUNTRY, 1/1/2009 TO
5/31/2011 (%) 137
PATENTS BY EMPHASIS 137
TABLE 77 PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011 138
FIGURE 54 NUMBER OF US PATENTS, BY EMPHASIS, 1/1/2009 TO
5/31/2011 138
CHAPTER SIXTEEN: CURRENT ENVIRONMENT 139
SITUATION OF THE NORTH AMERICAN CONTRACTING
MARKETS 139
CONTRACT MANUFACTURING OF API AND DOSAGE
FORMS 139
CONTRACT MANUFACTURING OF OTC AND
NUTRACEUTICALS 139
CONTRACT RESEARCH 140
CONTRACT PACKAGING 140
SITUATION OF THE EUROPEAN CONTRACTING MARKET 140
CONTRACT MANUFACTURING OF API AND DOSAGE
FORMS 140
CONTRACT MANUFACTURING OF OTC AND
NUTRACEUTICALS 140
CONTRACT RESEARCH 141
CONTRACT PACKAGING 141
SITUATION OF THE ROW CONTRACTING MARKET 141
CONTRACT MANUFACTURING OF API AND DOSAGE
FORMS 141
CONTRACT MANUFACTURING OF OTC AND
NUTRACEUTICALS 141
CONTRACT RESEARCH 142
CONTRACT PACKAGING 142
OPPORTUNITIES AND CHALLENGES OF THE CURRENT
CONTRACT MANUFACTURING INDUSTRY 142
OPPORTUNITIES AND CHALLENGES…(CONTINUED) 143
OPPORTUNITIES AND CHALLENGES…(CONTINUED) 144
CHAPTER SEVENTEEN: COMPANY PROFILES 145
AAI PHARMA, INC 145
ABBOTT LABORATORIES 145
AEROGEN LTD 146
ALKERMES 146
ALTHEA TECHNOLOGIES 147
AMCOR 148
AMERISOURCE BERGEN CORPORATION 148
AMPAC FINE CHEMICALS 149
ALBANY MOLECULAR RESEARCH INC (AMRI) 149
AP PHARMA INC 150
APTUIT INC 150
ARADIGM CORPORATION 151
BASF SE 152
BAXTER HEALTHCARE 152
BCM/BOOTS MANUFACTURING 153
BOEHRINGER INGELHEIM 154
BRISTOL-MYERS SQUIBB 154
CAMBREX CORPORATION 155
CANGENE CORPORATION 156
CATALENT PHARMA SOLUTIONS 156
CEDARBURG HAUSER PHARMACEUTICALS INC 157
CENEXI 157
CHARLES RIVER LABORATORIES 158
CHEMBRIDGE CORP 158
CLEARSTONE CENTRAL LABORATORIES 159
CONFAB LABORATORIES 159
COVANCE INC 160
COVIDIEN 160
CONTRACT PHARMACEUTICALS LIMITED 161
CORDEN PHARMA SWITZERLAND LLC 161
DAVOS PHARMA 162
DECODE GENETICS 162
DISHMAN PHARMACEUTICALS AND CHEMICALS LTD 163
DOW CHEMICAL 164
DPT LABORATORIES INC 164
DR REDDY'S LABORATORIES 165
DSM PHARMACEUTICAL PRODUCTS 165
FUJIFILM DIOSYNTH BIOTECHNOLOGY 166
ELAN DRUG TECHNOLOGIES 166
EVOTEC AG 167
FULCRUM PHARMA PLC 167
GIRINDUS AG 168
GLAXOSMITHKLINE 168
HOSPIRA 169
HAUPT PHARMA AG 170
HOVIONE SA 170
ICON PLC 171
INC RESEARCH, INC 171
JUBILANT LIFESCIENCES 172
KENDLE INTERNATIONAL INC 172
KP PHARMACEUTICAL TECHNOLOGIES INC 173
KV PHARMACEUTICAL CO 173
LIGAND PHARMACEUTICALS, INC 174
LONZA GROUP 174
LYNE LABORATORIES 175
MERCK / MSD BIOMANUFACTURING NETWORK 176
MIKART INC 176
NEXTPHARMA TECHNOLOGIES 177
NORWICH PHARMACEUTICALS 177
NOVAVAX, INC 178
OMNICARE CLINICAL RESEARCH 178
PAREXEL INTERNATIONAL CORPORATION 179
PATHEON INC 179
PERRIGO COMPANY 180
PFIZER (KING PHARMACEUTICALS 181
PIRAMAL HEALTHCARE LIMITED 181
PPD 182
PRA INTERNATIONAL 182
QUINTILES 183
RANBAXY 183
REGIS TECHNOLOGIES, INC 184
SKYEPHARMA 184
TALECRIS BIOTHERAPEUTICS INC 185
VETTER PHARMA INTERNATIONAL GMBH 185
WOCKHARDT LIMITED 186
WUXI APP TEC 187
XCELLEREX LLC 187
ZACH SYSTEM SPA 188
APPENDIX I: ABBREVIATIONS 189
To order this report:
Manufacturing Industry: Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets
Manufacturing Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article